David Macias

David Macias

Auto-generated profile, based on publicly available information

David Macias

Early Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, UK

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2017 in Cancer Cell
Verified
Journal Article
Open access
APAsís Palazón
Asís Palazón
PTPetros A. Tyrakis
Petros A. Tyrakis
DMDavid Macias
David Macias
PVPedro Veliça
Pedro Veliça
HRHelene Rundqvist
Helene Rundqvist
RJRandall S. Johnson
Randall S. Johnson
Cytotoxic T cells infiltrating tumors are thought to utilize HIF transcription factors during adaptation to the hypoxic tumor microenvironment. Deletion analyses of the two key HIF isoforms found that HIF-1α, but not HIF-2α, was essential for the effector state in CD8+ T cells. Furthermore, loss of HIF-1α in CD8+ T cells reduced tumor infiltration and tumor cell killing, and altered tumor vascularization. Deletion of VEGF-A, an HIF target gene, in CD8+ T cells accelerated tumorigenesis while also altering vascularization. Analyses of human breast cancer showed inverse correlations between VEGF-A expression and CD8+ T cell infiltration, and a link between T cell infiltration and vascularization. These data demonstrate that the HIF-1α/VEGF-A axis is an essential aspect of tumor immunity.

26 October 2016 in Nature
Verified
Journal Article
Open access
PDF file
PTPetros A. Tyrakis
Petros A. Tyrakis
APAsís Palazón
Asís Palazón
DMDavid Macias
David Macias
KLKian. L. Lee
Kian. L. Lee
APAnthony. T. Phan
Anthony. T. Phan
RJRandall S. Johnson
Randall S. Johnson
R-2-hydroxyglutarate accumulates to millimolar levels in cancer cells with gain-of-function isocitrate dehydrogenase 1/2 mutations. These levels of R-2-hydroxyglutarate affect 2-oxoglutarate-dependent dioxygenases. Both metabolite enantiomers, R- and S-2-hydroxyglutarate, are detectible in healthy individuals, yet their physiological function remains elusive. Here we show that 2-hydroxyglutarate accumulates in mouse CD8+ T cells in response to T-cell receptor triggering, and accumulates to millimolar levels in physiological oxygen conditions through a hypoxia-inducible factor 1-alpha (HIF-1α)-dependent mechanism. S-2-hydroxyglutarate predominates over R-2-hydroxyglutarate in activated T cells, and we demonstrate alterations in markers of CD8+ T-cell differentiation in response to this metabolite. Modulation of histone and DNA demethylation, as well as HIF-1α stability, mediate these effects. S-2-hydroxyglutarate treatment greatly enhances the in vivo proliferation, persistence and anti-tumour capacity of adoptively transferred CD8+ T cells. Thus, S-2-hydroxyglutarate acts as an immunometabolite that links environmental context, through a metabolic–epigenetic axis, to immune fate and function.

1 September 2019 in Cell Stem Cell
Verified
Journal Article
Open access
YHYa-Hsuan Ho
Ya-Hsuan Ho
RTRaquel del Toro
Raquel del Toro
JRJosé Rivera-Torres
José Rivera-Torres
JRJustyna Rak
Justyna Rak
CKClaudia Korn
Claudia Korn
SMSimón Méndez-Ferrer
Simón Méndez-Ferrer
Hematopoietic stem cells (HSCs) residing in the bone marrow (BM) accumulate during aging but are functionally impaired. However, the role of HSC-intrinsic and -extrinsic aging mechanisms remains debated. Megakaryocytes promote quiescence of neighboring HSCs. Nonetheless, whether megakaryocyte-HSC interactions change during pathological/natural aging is unclear. Premature aging in Hutchinson-Gilford progeria syndrome recapitulates physiological aging features, but whether these arise from altered stem or niche cells is unknown. Here, we show that the BM microenvironment promotes myelopoiesis in premature/physiological aging. During physiological aging, HSC-supporting niches decrease near bone but expand further from bone. Increased BM noradrenergic innervation promotes β2-adrenergic-receptor(AR)-interleukin-6-dependent megakaryopoiesis. Reduced β3-AR-Nos1 activity correlates with decreased endosteal niches and megakaryocyte apposition to sinusoids. However, chronic treatment of progeroid mice with β3-AR agonist decreases premature myeloid and HSC expansion and restores the proximal association of HSCs to megakaryocytes. Therefore, normal/premature aging of BM niches promotes myeloid expansion and can be improved by targeting the microenvironment.

31 March 2020 in Aging Cell
Verified
Journal Article
Open access
PDF file
EGEstela González‐Gualda
Estela González‐Gualda
MPMarta Pàez‐Ribes
Marta Pàez‐Ribes
BLBeatriz Lozano‐Torres
Beatriz Lozano‐Torres
DMDavid Macias
David Macias
JWJoseph R. Wilson
Joseph R. Wilson
DMDaniel Muñoz‐Espín
Daniel Muñoz‐Espín
Pharmacologically active compounds with preferential cytotoxic activity for senescent cells, known as senolytics, can ameliorate or even revert pathological manifestations of senescence in numerous preclinical mouse disease models, including cancer models. However, translation of senolytic therapies to human disease is hampered by their suboptimal specificity for senescent cells and important toxicities that narrow their therapeutic windows. We have previously shown that the high levels of senescence‐associated lysosomal β‐galactosidase (SA‐β‐gal) found within senescent cells can be exploited to specifically release tracers and cytotoxic cargoes from galactose‐encapsulated nanoparticles within these cells. Here, we show that galacto‐conjugation of the BCL‐2 family inhibitor Navitoclax results in a potent senolytic prodrug (Nav‐Gal), that can be preferentially activated by SA‐β‐gal activity in a wide range of cell types. Nav‐Gal selectively induces senescent cell apoptosis and has a higher senolytic index than Navitoclax (through reduced activation in nonsenescent cells). Nav‐Gal enhances the cytotoxicity of standard senescence‐inducing chemotherapy (cisplatin) in human A549 lung cancer cells. Concomitant treatment with cisplatin and Nav‐Gal in vivo results in the eradication of senescent lung cancer cells and significantly reduces tumour growth. Importantly, galacto‐conjugation reduces Navitoclax‐induced platelet apoptosis in human and murine blood samples treated ex vivo, and thrombocytopenia at therapeutically effective concentrations in murine lung cancer models. Taken together, we provide a potentially versatile strategy for generating effective senolytic prodrugs with reduced toxicities.

18 July 2016 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
ACAndrew S. Cowburn
Andrew S. Cowburn
ACAlexi Crosby
Alexi Crosby
DMDavid Macias
David Macias
CBCristina Branco
Cristina Branco
RCRenato D. D. R. Colaço
Renato D. D. R. Colaço
RJRandall S. Johnson
Randall S. Johnson
Significance: The expression of hypoxia-inducible factor (HIF)-2α in pulmonary endothelium of mice influences pulmonary vascular resistance and development of hypoxic pulmonary hypertension (PH) via an arginase-1–dependent mechanism. The HIF-2α:arginase-1 axis influences the homeostatic regulation of nitric oxide synthesis in the lung. Impaired generation of this vasoactive agent contributes to the initial development and vascular remodeling process of PH.

1 February 2016 in Molecular Aspects of Medicine
Verified
Journal Article
Closed access
JLJosé López-Barneo
José López-Barneo
POPatricia Ortega-Sáenz
Patricia Ortega-Sáenz
PGPatricia González-Rodríguez
Patricia González-Rodríguez
MFM. Carmen Fernández-Agüera
M. Carmen Fernández-Agüera
DMDavid Macías
David Macías
LGLin Gao
Lin Gao